Clovis Oncology, Inc. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Clovis Oncology, Inc. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $89.40 million as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2018-02-27
- 2017-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $89.40M.
- 2016-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $86.80M.
- 2012-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $13.30M.
- 2012-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $14.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2017-12-31 | $89.40M 10-K · filed 2018-02-27 |
| 2016-12-31 | $86.80M 10-K · filed 2017-02-23 |
| 2012-09-30 | $13.30M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $14.60M 10-Q · filed 2012-08-10 |